Reata Pharmaceuticals, Inc. Stock
Equities
RETA
US75615P1030
Biotechnology & Medical Research
Latest transcript on Reata Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director of Finance/CFO | 60 | 23-09-25 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director/Board Member | - | 23-09-25 | |
Michael Dambach
BRD | Director/Board Member | - | 23-09-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 773 M€ | -.--% | - | |
0.04% | 509 M€ | -.--% |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |